JAMES BOWLDS: Open Payments
NPI 1760074041 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,561 in 95 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,399 · 2025 $2,561
Food & beverage: $2,346Education: $215
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 14 | $301 |
| Janssen Biotech, Inc. | 9 | $300 |
| Galderma Laboratories, L.P. | 8 | $299 |
| ABBVIE INC. | 16 | $274 |
| Regeneron Healthcare Solutions, Inc. | 6 | $271 |
| GENZYME CORPORATION | 5 | $253 |
| Novartis Pharmaceuticals Corporation | 14 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $202 |
| Organon LLC | 1 | $84 |
| UCB, Inc. | 3 | $68 |
Products named: DUPIXENT, Zoryve, TREMFYA, NEMLUVIO, SKYRIZI, COSENTYX, VTAMA, ILUMYA.
Industry payments across KY — which companies pay providers there.
